Financial reports
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
28 Feb 22
Current reports
8-K
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
25 Mar 24
8-K
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
29 Feb 24
8-K
Departure of Directors or Certain Officers
8 Jan 24
8-K
Departure of Directors or Certain Officers
14 Dec 23
8-K
Departure of Directors or Certain Officers
27 Nov 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
8-K
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
2 Nov 23
8-K
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 May 23
8-K
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
4 May 23
Registration and prospectus
S-8
Registration of securities for employees
4 Mar 24
S-8
Registration of securities for employees
16 Mar 23
S-8
Registration of securities for employees
26 Aug 22
424B3
Prospectus supplement
11 Apr 22
POS AM
Prospectus update (post-effective amendment)
2 Mar 22
424B3
Prospectus supplement
1 Feb 22
424B3
Prospectus supplement
10 Jan 22
424B3
Prospectus supplement
10 Nov 21
424B3
Prospectus supplement
12 Aug 21
S-8
Registration of securities for employees
8 Jun 21
Proxies
Other
EFFECT
Notice of effectiveness
8 Apr 22
EFFECT
Notice of effectiveness
1 Jun 21
EFFECT
Notice of effectiveness
1 Apr 21
CORRESP
Correspondence with SEC
29 Mar 21
UPLOAD
Letter from SEC
18 Mar 21
EFFECT
Notice of effectiveness
21 Jan 21
SEC STAFF
SEC staff action: Order
19 Jan 21
CORRESP
Correspondence with SEC
19 Jan 21
CORRESP
Correspondence with SEC
8 Jan 21
UPLOAD
Letter from SEC
31 Dec 20